ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,699Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 1269

$774K Total Retail Price of All Prescriptions

Rank: 47 out of 1269

389 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 5,662 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
OMEPRAZOLE 659 238 1 8
RISPERIDONE 460 126 2 43
LEVOTHYROXINE SODIUM 403 156 3 4
DIVALPROEX SODIUM 391 96 4 54
ALENDRONATE SODIUM 388 180 5 28
ATORVASTATIN CALCIUM 359 239 6 7
SIMVASTATIN 331 171 7 3
AMLODIPINE BESYLATE 283 217 8 2
LISINOPRIL 261 167 9 1
FUROSEMIDE 208 147 10 5
METOPROLOL SUCCINATE 168 146 11 13
HYDROCHLOROTHIAZIDE 167 77 12 10
METOPROLOL TARTRATE 160 89 13 6
PRAVASTATIN SODIUM 157 79 14 11
QUETIAPINE FUMARATE 147 49 15 53
METFORMIN HCL 136 82 16 9
LIPITOR 131 83 17 91
PAROXETINE HCL 130 68 18 71
DIOVAN 128 104 19 35
ZOLPIDEM TARTRATE 124 63 20 19
SERTRALINE HCL 120 75 21 23
METOCLOPRAMIDE HCL 119 0 22 155
SINGULAIR 117 29 23 123
KETOCONAZOLE 116 57 24 203
PANTOPRAZOLE SODIUM 114 40 25 18
BENZTROPINE MESYLATE 109 23 R 26 108
LEVETIRACETAM 107 17 27 55
TAMSULOSIN HCL 105 80 28 31
RANITIDINE HCL 104 41 29 27
NEXIUM 103 68 30 41
FLUTICASONE PROPIONATE 96 40 31 40
POLYETHYLENE GLYCOL 3350 91 35 32 50
TRAZODONE HCL 91 36 32 36
CARBAMAZEPINE 86 13 34 148
MELOXICAM 84 55 35 68
FLUVOXAMINE MALEATE 82 0 36 333
CYMBALTA 82 53 36 70
LACTULOSE 76 35 38 67
MONTELUKAST SODIUM 73 20 39 218
WARFARIN SODIUM 68 58 40 12
SEROQUEL 67 18 41 104
CRESTOR 66 66 42 25
VALPROIC ACID 60 0 43 189
ATENOLOL 59 56 44 14
IBUPROFEN 59 22 44 73
OLANZAPINE 59 11 44 89
DIVALPROEX SODIUM ER 58 0 47 176
PHENYTOIN SODIUM EXTENDED 57 0 48 137
LANSOPRAZOLE 57 33 48 120
FLUOXETINE HCL 55 0 50 83
CHLORHEXIDINE GLUCONATE 54 21 51 191
DONEPEZIL HCL 52 33 52 22
HALOPERIDOL 52 12 52 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.